Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion type Assertion NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_head.
- NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion description "[Due to the heterogeneity of prostate cancer, the combination of several biomarkers is necessary to accurately assess the presence of prostate cancer, predict its potential clinical outcome and decide on appropriate therapy (e.g.PARP inhibitors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_provenance.
- NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion evidence source_evidence_literature NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_provenance.
- NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion SIO_000772 25485532 NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_provenance.
- NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion wasDerivedFrom befree-2016 NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_provenance.
- NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion wasGeneratedBy ECO_0000203 NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_provenance.